ArticleJPRAS open2026
Investigation of the therapeutic effect of orbital septum transfer in the reconstruction of severe eyelid defects.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the efficacy of skin flap and orbital septum transfer combined with allogeneic sclera transplantation for the reconstruction of full-thickness eyelid defects after malignant eyelid tumor resection. Methods: Twenty one patients from our hospital who were diagnosed with malignant tumors of the eyelid through pathological examination and had severe eyelid defects after extensive tumor resection, including eleven patients with eyelid basal cell carcinoma, seven patients with sebaceous gland carcinoma and three patients with squamous cell carcinoma. The tumors were all located on the lower eyelid. The anterior layer was reconstructed using upper eyelid rotational skin flap transfer, while the posterior layer was reconstructed using autologous orbital septum transfer and allogeneic sclera transplantation. After surgery, eyelid closure, eyelid and palpebral margin morphology, transplanted skin condition, local foreign body sensation, and ocular surface condition were observed. Results: All patients underwent controlled mass resection using specimen-labelled frozen sections during surgery. After that, severe eyelid defects were observed, with one patient undergoing secondary eyelid reconstruction and the remaining patients undergoing primary eyelid reconstruction. After 6-month follow-up, all the patients had satisfactory eyelid closure, satisfactory eyelid and palpebral margin morphology, no local discomfort caused by foreign bodies, smooth orbital septum, good corneal condition on the ocular surface, and no tumor recurrence. Conclusion: In terms of severe eyelid defects, the use of upper eyelid rotational skin flap transfer to reconstruct the anterior layer, autologous orbital septum transfer, and allogeneic sclera transplantation to reconstruct the posterior layer is safe, effective, and reproducible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.